AURX
vs
IONS
AURX
IONS
Over the past 12 months, AURX has underperformed IONS, delivering a return of +23% compared to the IONS's +150% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
AURX
IONS
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
Nuo Therapeutics Inc
OTC:AURX
|
1.5
USD
|
|||||
|
Ionis Pharmaceuticals Inc
NASDAQ:IONS
|
81.64
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
AURX, IONS
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
Nuo Therapeutics Inc
Revenue
|
|||||||||||
|
Ionis Pharmaceuticals Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
AURX, IONS
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
Nuo Therapeutics Inc
OTC:AURX
|
|||||||||
|
Ionis Pharmaceuticals Inc
NASDAQ:IONS
|
|||||||||
Compare company's free cash flow with its competitors.
Gross Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Nuo Therapeutics Inc | ||||
|
Ionis Pharmaceuticals Inc | ||||
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Nuo Therapeutics Inc | ||||
|
Ionis Pharmaceuticals Inc | ||||
Net Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Nuo Therapeutics Inc | ||||
|
Ionis Pharmaceuticals Inc | ||||
FCF Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Nuo Therapeutics Inc | ||||
|
Ionis Pharmaceuticals Inc | ||||
ROA
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Nuo Therapeutics Inc | ||||
|
Ionis Pharmaceuticals Inc | ||||
ROIC
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Nuo Therapeutics Inc | ||||
|
Ionis Pharmaceuticals Inc | ||||
ROCE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Nuo Therapeutics Inc | ||||
|
Ionis Pharmaceuticals Inc | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
AURX, IONS
Performance By Year
AURX, IONS
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
|
| US |
S
|
Seagen Inc
F:SGT
|
|
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
|
| US |
|
Ionis Pharmaceuticals Inc
NASDAQ:IONS
|
|
| US |
|
Gartner Inc
NYSE:IT
|
|
| US |
|
Charles River Laboratories International Inc
NYSE:CRL
|
|
| US |
|
Halozyme Therapeutics Inc
NASDAQ:HALO
|
|
| IE |
|
ICON PLC
NASDAQ:ICLR
|
|
| US |
|
Cytokinetics Inc
NASDAQ:CYTK
|
|
| UK |
|
Verona Pharma PLC
NASDAQ:VRNA
|